Andromeda Biotech

Andromeda Biotech is developing an innovative new treatment for type 1 diabetes.

The company’s lead produat, Diapep 277®, is currently in phase 3 trials, and is poised to revolutionize the treatment, and longterm prognosis of this incurable, degenerative disease.

Leave a Comment

You must be logged in to post a comment.

  • A 5-minute overview of a new drug for the treatment of type 1 diabetes

  • Services:

    • ● Directing
    • ● Writing
    • ● Editing
    • ● Animation
    • ● Production
Back to Portfolio